< Back
EMWA Logo EMWA Logo
 

Tracy Farrow

Company:
PPD
Qualification:
GIBiol
Leader background:
Tracy is currently Senior Director, Medical Writing for PPD where she is responsible for EMEA and APAC medical writing and PPD’s global data transparency initiative. Tracy has more than 25 years of Biomedical Science experience. Before PPD she worked for ClinTec International as Manager, Medical Writing Services; and Pfizer as Medical Writing Therapeutic Area Lead, and Quality Manager for Data Management where she was responsible for data privacy training, audit management, SOP and best practice development. She lectured in Intermediate Laboratory Data Management for the Association for Clinical Data Management for a number of years as part of their professional development program. She attained her 2.1 (Hons) GI Biol in Biochemistry in 1993 after gaining two Higher National Certificates in Haematology and Chemistry. From May 2014, Tracy has been a member of the EMWA-AMWA Budapest Working Group Oversight Review Team, with special responsibility for the area of transparency and public disclosure in relation to clinical-regulatory documents.
Workshops:
Good SOP Practice: Processes and Authoring
    Level: Foundation Area: Drug Development
    Code: DDF18 Duration: 03:30:00
An Introduction to Clinical Trial Disclosure – the Regulatory Requirements, Industry Commitments, and Protection of Data Privacy and Company Confidential Information
    Level: Foundation Area: Drug Development
    Code: DDF36 Duration: 03:30:00
The Impact of Clinical Trial Data Disclosure on Trial-related Documents: Redaction Requirements and Future Document Structure
    Level: Expert Seminar Series Area: Seminar
    Code: ESS10 Duration: 01:30:00
CORE Reference - Clarity and Openness in Reporting: E3-based
    Level: Foundation Area: Drug Development
    Code: DDF38 Duration: 03:30:00
CORE Reference - Clarity and Openness in Reporting: E3-based
    Level: Foundation Area: Drug Development
    Code: DDF38a Duration: 03:30:00
Update on CORE
    Level: Area:
    Code: Sym5.8 Duration: 00:15:00
CORE Reference - Clarity and Openness in Reporting: E3 based
    Level: Foundation Area: Drug Development
    Code: DDF38b Duration: 03:30:00
CORE Reference - Clarity and Openness in Reporting: E3 based
    Level: Foundation Area: Drug Development
    Code: DDF38c Duration: 03:30:00